Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anne Gulbins

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Frontiers in Endocrinology|April 21, 2023
Sphingolipids in thyroid eye diseaseAnne Gulbins, Gina-Eva Görtz, Erich Gulbins, et al.
Neuro-Signals|August 4, 2016
Role of Janus-Kinases in Major Depressive DisorderAnne Gulbins, Heike Grassmé, Richard Hoehn, et al.
Klinische Monatsblatter Fur Augenheilkunde|October 6, 2023
Current Therapeutic Approaches for Graves' Orbitopathy - are Targeted Therapies the Future?Anja Eckstein, Mareile Stöhr, Gina-Eva Görtz, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|August 1, 2016
Regulation of Neuronal Stem Cell Proliferation in the Hippocampus by Endothelial CeramideAnne Gulbins, Heike Grassmé, Richard Hoehn, et al.
Frontiers in Endocrinology|March 16, 2026
Maraviroc attenuates orbital remodeling, inflammation, and lipid dysregulation in a murine model of thyroid eye disease associated with Graves' diseaseFahimeh Hashemi Arani, Anne Gulbins, Mareike Horstmann, et al.
Frontiers in Endocrinology|October 9, 2023
Potential involvement of the bone marrow in experimental Graves' disease and thyroid eye diseaseAnne Gulbins, Mareike Horstmann, Simone Keitsch, et al.
Molecular Psychiatry|July 25, 2018
Antidepressants act by inducing autophagy controlled by sphingomyelin-ceramideAnne Gulbins, Fabian Schumacher, Katrin Anne Becker, et al.
Frontiers in Endocrinology|July 12, 2023
Linsitinib, an IGF-1R inhibitor, attenuates disease development and progression in a model of thyroid eye diseaseAnne Gulbins, Mareike Horstmann, Anke Daser, et al.
The Journal of Biological Chemistry|September 12, 2020
Sphingosine prevents binding of SARS-CoV-2 spike to its cellular receptor ACE2Michael J Edwards, Katrin Anne Becker, Barbara Gripp, et al.
Cell Reports. Medicine|November 9, 2020
Pharmacological Inhibition of Acid Sphingomyelinase Prevents Uptake of SARS-CoV-2 by Epithelial CellsAlexander Carpinteiro, Michael J Edwards, Markus Hoffmann, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Frontiers in Endocrinology|April 21, 2023
Sphingolipids in thyroid eye diseaseAnne Gulbins, Gina-Eva Görtz, Erich Gulbins, et al.
Neuro-Signals|August 4, 2016
Role of Janus-Kinases in Major Depressive DisorderAnne Gulbins, Heike Grassmé, Richard Hoehn, et al.
Klinische Monatsblatter Fur Augenheilkunde|October 6, 2023
Current Therapeutic Approaches for Graves' Orbitopathy - are Targeted Therapies the Future?Anja Eckstein, Mareile Stöhr, Gina-Eva Görtz, et al.
Cellular Physiology and Biochemistry : International Journal of Experimental Cellular Physiology, Biochemistry, and Pharmacology|August 1, 2016
Regulation of Neuronal Stem Cell Proliferation in the Hippocampus by Endothelial CeramideAnne Gulbins, Heike Grassmé, Richard Hoehn, et al.
Frontiers in Endocrinology|March 16, 2026
Maraviroc attenuates orbital remodeling, inflammation, and lipid dysregulation in a murine model of thyroid eye disease associated with Graves' diseaseFahimeh Hashemi Arani, Anne Gulbins, Mareike Horstmann, et al.
Frontiers in Endocrinology|October 9, 2023
Potential involvement of the bone marrow in experimental Graves' disease and thyroid eye diseaseAnne Gulbins, Mareike Horstmann, Simone Keitsch, et al.
Molecular Psychiatry|July 25, 2018
Antidepressants act by inducing autophagy controlled by sphingomyelin-ceramideAnne Gulbins, Fabian Schumacher, Katrin Anne Becker, et al.
Frontiers in Endocrinology|July 12, 2023
Linsitinib, an IGF-1R inhibitor, attenuates disease development and progression in a model of thyroid eye diseaseAnne Gulbins, Mareike Horstmann, Anke Daser, et al.
The Journal of Biological Chemistry|September 12, 2020
Sphingosine prevents binding of SARS-CoV-2 spike to its cellular receptor ACE2Michael J Edwards, Katrin Anne Becker, Barbara Gripp, et al.
Cell Reports. Medicine|November 9, 2020
Pharmacological Inhibition of Acid Sphingomyelinase Prevents Uptake of SARS-CoV-2 by Epithelial CellsAlexander Carpinteiro, Michael J Edwards, Markus Hoffmann, et al.
Pageof 1